References 1 VaduganathanMMensahGATurcoJVFusterVRothGA
Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: a childrens oncology group report
The second NPC approval in a week highlights the FDAs commitment to supporting the development of innovative therapies for rare diseases, Janet Maynard, director of the FDAs Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine, said in a statement
Finally, a possible effect of the GSTO1 and GSTO2 loci on the age at onset of ALS was also reported 67
To enhance the residence time of G/D at the joint site, liposomes were employed to encapsulate the nanogels to obtain a liposomal drug depot
H tr thanh lc cc cht c trong gan, gim nguy c b gan nhim m, ung th gan, x gan